These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38688000)

  • 1. Correction to Chemically Modified Platforms for Better RNA Therapeutics.
    Shi Y; Zhen X; Zhang Y; Li Y; Koo S; Saiding Q; Kong N; Liu G; Chen W; Tao W
    Chem Rev; 2024 May; 124(10):6690-6692. PubMed ID: 38688000
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemically Modified Platforms for Better RNA Therapeutics.
    Shi Y; Zhen X; Zhang Y; Li Y; Koo S; Saiding Q; Kong N; Liu G; Chen W; Tao W
    Chem Rev; 2024 Feb; 124(3):929-1033. PubMed ID: 38284616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of Gene Knockdown on CD22-Expressing Cells by Chemically Modified Glycan Ligand-siRNA Conjugates.
    Harumoto T; Iwai H; Tanigawa M; Kubo T; Atsumi T; Tsutsumi K; Takashima M; Destito G; Soloff R; Tomizuka K; Nycholat C; Paulson J; Uehara K
    ACS Chem Biol; 2022 Feb; 17(2):292-298. PubMed ID: 35020348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery platforms for RNA therapeutics.
    Ciucci G; Braga L; Zacchigna S
    Br J Pharmacol; 2024 May; ():. PubMed ID: 38760893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oral and craniofacial relevance of chemically modified RNA therapeutics.
    Elangovan S; Kormann MS; Khorsand B; Salem AK
    Discov Med; 2016 Jan; 21(113):35-9. PubMed ID: 26896600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatography purification of chemically modified RNA aptamers.
    Lin CY; Huang Z; Jaremko W; Niu L
    Anal Biochem; 2014 Mar; 449():106-8. PubMed ID: 24373999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII.
    Huynh HT; Grubb JH; Vogler C; Sly WS
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17022-7. PubMed ID: 23027951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Short Chemically Modified dsRNA-Binding PNA (dbPNA) Inhibits Influenza Viral Replication by Targeting Viral RNA Panhandle Structure.
    Kesy J; Patil KM; Kumar SR; Shu Z; Yong HY; Zimmermann L; Ong AAL; Toh DK; Krishna MS; Yang L; Decout JL; Luo D; Prabakaran M; Chen G; Kierzek E
    Bioconjug Chem; 2019 Mar; 30(3):931-943. PubMed ID: 30721034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of chemically modified siRNA: Recent trends.
    Selvam C; Mutisya D; Prakash S; Ranganna K; Thilagavathi R
    Chem Biol Drug Des; 2017 Nov; 90(5):665-678. PubMed ID: 28378934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Antimicrobial Potential of a Chemically Modified Peptide From Its Tertiary Structure.
    Agrawal P; Raghava GPS
    Front Microbiol; 2018; 9():2551. PubMed ID: 30416494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemical Approaches for RNAi Drug Development].
    Saito-Tarashima N
    Yakugaku Zasshi; 2020; 140(10):1259-1268. PubMed ID: 32999205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights from crystallographic studies into the structural and pairing properties of nucleic acid analogs and chemically modified DNA and RNA oligonucleotides.
    Egli M; Pallan PS
    Annu Rev Biophys Biomol Struct; 2007; 36():281-305. PubMed ID: 17288535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembling the RNA therapeutics toolbox.
    Teng M; Xia ZJ; Lo N; Daud K; He HH
    Med Rev (2021); 2024 Apr; 4(2):110-128. PubMed ID: 38680684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNAmod: A database of experimentally validated chemically modified siRNAs.
    Dar SA; Thakur A; Qureshi A; Kumar M
    Sci Rep; 2016 Jan; 6():20031. PubMed ID: 26818131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Nanoparticles for Effective Delivery of RNA Therapeutics.
    Byun MJ; Lim J; Kim SN; Park DH; Kim TH; Park W; Park CG
    Biochip J; 2022; 16(2):128-145. PubMed ID: 35261724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How the initial discovery of modified RNA enabled evasion of innate immune responses and facilitated the development of RNA therapeutics.
    Sioud M
    Scand J Immunol; 2023 Jul; 98(1):e13282. PubMed ID: 37132451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene silencing by chemically modified siRNAs.
    Engels JW
    N Biotechnol; 2013 Mar; 30(3):302-7. PubMed ID: 22820489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo quantification of formulated and chemically modified small interfering RNA by heating-in-Triton quantitative reverse transcription polymerase chain reaction (HIT qRT-PCR).
    Landesman Y; Svrzikapa N; Cognetta A; Zhang X; Bettencourt BR; Kuchimanchi S; Dufault K; Shaikh S; Gioia M; Akinc A; Hutabarat R; Meyers R
    Silence; 2010 Aug; 1(1):16. PubMed ID: 20731861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing.
    Chen Q; Zhang Y; Yin H
    Adv Drug Deliv Rev; 2021 Jan; 168():246-258. PubMed ID: 33122087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.